Picture of Adocia SA logo

ADOC Adocia SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Adocia Files Patent On Hydrogen Scaffold For Type 1 Diabetes Treatment

Jan 11 (Reuters) - Adocia  ADOC.PA :
    * ANNOUNCED ON SATURDAY FILING PATENT ON A HYDROGEN SCAFFOLD
FOR
CELL THERAPY IN THE TREATMENT OF TYPE 1 DIABETES
    * HYDROGEL SCAFFOLD CONTAINING PANCREATIC CELLS COULD
RESTORE
GLYCEMIC CONTROL WITHOUT REQUIRING INSULIN INJECTION AND
IMMUNOSUPPRESSANT DRUGS

 Source text for Eikon:  urn:newsml:reuters.com:*:nBw4yXfNqa
    
 Further company coverage:  ADOC.PA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))

Recent news on Adocia SA

See all news